Stivarga

reshuffle pipeline target reorganize shift change
Biotech

ESMO: Exelixis' TKI reduces risk of death by 20%

The company believes the data for zanzalintinib validate its hopes of having another “franchise molecule” on its hands.
James Waldron Oct 20, 2025 2:30am
Job cuts employee layoffs firings or downsizing Scissors dividing individuals positioned on colorful blocks

Exelixis plans shuttering of East Coast site, 130 layoffs

Aug 29, 2025 9:15am
Despite Frances high threat level hotel stays reached 1071 million

Phase 3 hepatocellular carcinoma fail crushes Onxeo

Sep 12, 2017 10:12am
colorectal

ASCO: Chi-Med touts fruquintinib's phase 3 safety edge

Jun 5, 2017 6:24pm